DermaLab Benelux: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DermaLab Benelux
Largest movements
- Stocks and contracts +€64,086
new in 2024: €64,086
- Cash +€45,782
up €45,782 (+1,831%), from €2,500 to €48,282
mainly Tax, wage and social debts (+€61,516) and Net result for the year (+€49,778)
- Receivables within one year +€19,954
new in 2024: €19,954
- Deferred charges and accrued income +€2,541
new in 2024: €2,541
- Tax, wage and social debts +€61,516
new in 2024: €61,516
- Reserves +€47,448
new in 2024: €47,448
- Other debts +€19,693
new in 2024: €19,693
- Profit (loss) carried forward +€2,330
no longer reported in 2024 (was -€2,330)
- Gross operating margin +€67,576
up €67,576, from -€2,106 to €65,470
- Taxes +€17,337
new in 2024: €17,337
- Financial income +€5,725
new in 2024: €5,725
- Financial charges +€2,308
new in 2024: €2,308
- Other operating charges +€1,548
up €1,548 (+691%), from €224 to €1,771
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,500 | €134,864 | +€132,364 | +5,295% |
| Current assets | 29/58 | €2,500 | €134,864 | +€132,364 | +5,295% |
| Stocks and contracts in progress | 3 | - | €64,086 | +€64,086 | |
| Stocks | 30/36 | - | €64,086 | +€64,086 | |
| Amounts receivable within one year | 40/41 | - | €19,954 | +€19,954 | |
| Trade receivables | 40 | - | €19,954 | +€19,954 | |
| Cash at bank and in hand | 54/58 | €2,500 | €48,282 | +€45,782 | +1,831% |
| Deferred charges and accrued income | 490/1 | - | €2,541 | +€2,541 | |
| Total equity and liabilities | 10/49 | €2,500 | €134,864 | +€132,364 | +5,295% |
| Equity | 10/15 | €170 | €49,948 | +€49,778 | +29,212% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | - | €47,448 | +€47,448 | |
| Distributable reserves | 133 | - | €47,448 | +€47,448 | |
| Profit (loss) carried forward | 14 | -€2,330 | - | +€2,330 | |
| Amounts payable | 17/49 | €2,330 | €84,915 | +€82,585 | +3,545% |
| Amounts payable within one year | 42/48 | €2,330 | €84,653 | +€82,323 | +3,534% |
| Trade debts | 44 | €2,330 | €3,444 | +€1,114 | +47.8% |
| Suppliers | 440/4 | €2,330 | €3,444 | +€1,114 | +47.8% |
| Taxes, remuneration and social security | 45 | - | €61,516 | +€61,516 | |
| Taxes | 450/3 | - | €61,516 | +€61,516 | |
| Other amounts payable | 47/48 | - | €19,693 | +€19,693 | |
| Accrued charges and deferred income | 492/3 | - | €262 | +€262 | |
| Other operating charges | 640/8 | €224 | €1,771 | +€1,548 | +691% |
| Gross operating margin | 9900 | -€2,106 | €65,470 | +€67,576 | |
| Operating profit (loss) | 9901 | -€2,330 | €63,698 | +€66,028 | |
| Financial income | 75/76B | - | €5,725 | +€5,725 | |
| Recurring financial income | 75 | - | €5,725 | +€5,725 | |
| Financial charges | 65/66B | - | €2,308 | +€2,308 | |
| Recurring financial charges | 65 | - | €2,308 | +€2,308 | |
| Profit (loss) for the period before taxes | 9903 | -€2,330 | €67,115 | +€69,444 | |
| Income taxes | 67/77 | - | €17,337 | +€17,337 | |
| Profit (loss) for the period | 9904 | -€2,330 | €49,778 | +€52,108 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,330 | €49,778 | +€52,108 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.